In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, CME Group Inc (NASDAQ: CME) closed at $268.34 down -0.79% from its previous closing price of $270.47. In other words, the price has decreased by -$0.79 from its previous closing price. On the day, 3.0 million shares were traded.
Ratios:
For a deeper understanding of CME Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 63.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.27. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.14.
On March 10, 2025, Raymond James Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $287.
Citigroup Downgraded its Buy to Neutral on January 06, 2025, whereas the target price for the stock was revised from $255 to $250.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 13 ’25 when GEPSMAN MARTIN J bought 300 shares for $267.50 per share.
Sammann Derek sold 4,650 shares of CME for $1,304,847 on May 05 ’25. The Sr MD Gl Hd Commodities Mkts now owns 8,336 shares after completing the transaction at $280.61 per share. On May 02 ’25, another insider, Sammann Derek, who serves as the Officer of the company, bought 4,650 shares for $281.20 each.
Valuation Measures:
As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.98, and their Forward P/E ratio for the next fiscal year is 23.13. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.39 while its Price-to-Book (P/B) ratio in mrq is 3.57.
Stock Price History:
Over the past 52 weeks, CME has reached a high of $286.48, while it has fallen to a 52-week low of $186.08. The 50-Day Moving Average of the stock is 1.32%, while the 200-Day Moving Average is calculated to be 15.01%.
Shares Statistics:
A total of 359.65M shares are outstanding, with a floating share count of 359.23M. Insiders hold about 0.31% of the company’s shares, while institutions hold 90.59% stake in the company.
Earnings Estimates
The performance of CME Group Inc (CME) in the stock market is under the watchful eye of 14.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $2.8, with high estimates of $3.09 and low estimates of $2.55.
Analysts are recommending an EPS of between $12.25 and $10.54 for the fiscal current year, implying an average EPS of $11.19. EPS for the following year is $11.64, with 17.0 analysts recommending between $12.65 and $10.54.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $1.68B this quarter.It ranges from a high estimate of $1.74B to a low estimate of $1.61B. As of the current estimate, CME Group Inc’s year-ago sales were $1.53BFor the next quarter, 8 analysts are estimating revenue of $1.61B. There is a high estimate of $1.66B for the next quarter, whereas the lowest estimate is $1.55B.
A total of 14 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.98B, while the lowest revenue estimate was $6.25B, resulting in an average revenue estimate of $6.54B. In the same quarter a year ago, actual revenue was $6.13BBased on 14 analysts’ estimates, the company’s revenue will be $6.85B in the next fiscal year. The high estimate is $7.54B and the low estimate is $6.34B.
